2Alvarez-Guerra M,Bertholom N,Garay RP.Elective blockade by nicergoline of vascular responses elicited by stimulation of alpha I A-adrenoceptor subtype in the rat[J].Fundam Clin Pharmacol,1999,13(1):1-4.
3Benzi G,De Bernardi M,Manzol L,et al.Effect of lysergide and nicergoline on glucose metabolism investigated on the dog brain isolated in situ[J].J Pharm Sci,1972,61:348-352.
4Carfagna N,Di-Clemente A,Cavanus S,et al.Odulation of hippocampal Ach release by chronic nicergoline treatment in freely moving young and aged rats[J].Neurosci Lett,1995,3:195-198.
5Davis RE,Emmerling MR,Jaen JC,et al.Therapeutic intervention in dementia[J].Crit Rev Neurobiol,1993,7:41-83.
6Carfagna N,Cavanus S,Damiani D,et al.Modulation of phosphoinositide turnover by chronic nicergoline in rat brain[J].NeurosciLett,1996,3:189-192.
7Chandra P,Paul A.The effect of nicergoline and other vasoactive substances on molecular biological processes in the brain and their effect on the learning abilities of rats.In:Heidrich H,ed.proof of therapeutical effectiveness of nootropic and vasoactive drufs[J].Berlin,Springer Verlag,1985:119-130.
8Asai S,Zhao H,Yamashita A,et al.Nicergoline enhances glutamate reuptake and protects against brain damage in rat global brain ischemia[J].Eur J Pharmacol,1999,383(3):267-274.
9Nagakawa Y,Akedo Y,Kaku S,et al.Effecl of nicergoline on platelet aggregation,plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction[J].Arzheimittel forschung,1990,8:862-864.
